Affinity and epitope profiling of mouse anti-CD40 monoclonal antibodies

Scandinavian Journal of Immunology

Volumn 57, Issue 6, 2003, Pages 517-524

  Hager, A C Malmborg ^a   Ellmark, P ^a   Borrebaeck, C A K ^a   Furebring, C ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; EPITOPE;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ANTIGENIC MODULATION; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; INHIBITION KINETICS; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIGENS, CD40; B-LYMPHOCYTES; CD40 LIGAND; CELL DIVISION; CELL LINE; EPITOPE MAPPING; HUMANS; KINETICS; LYMPHOCYTE ACTIVATION; MICE; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0038040565     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01271.x     Document Type: Article

References (31)

1. Bajorath J, Marken JS, Chalupny NJ et al. Analysis of gp39/CD40 interactions using molecular models and site- directed mutagenesis. Biochemistry 1995;34:9884-92.
2. Singh J, Garber E, Van Vlijmen H et al. The role of polar interactions in the molecular recognition of CD40L with its receptor CD40. Protein Sci 1998;7:1124-35.
3. Hsu YM, Lucci J, Su L, Ehrenfels B, Garber E, Thomas D. Heteromultimeric complexes of CD40 ligand are present on the cell surface of human T lymphocytes. J Biol Chem 1997;272:911-5.
4. Van Kooten C. Immune regulation by CD40-CD40L interactions -2; Y2K update. Front Biosci 2000;5:880-93.
5. Sakata N, Hamelmann E, Siadak AW et al. Differential regulation of CD40-mediated human B cell responses by antibodies directed against different CD40 epitopes. Cell Immunol 2000;201:109-23.
6. Lee HH, Dempsey PW, Parks TP, Zhu X, Baltimore D, Cheng G. Specificities of CD40 signalling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up- regulation. Proc Natl Acad Sci U S A 1999;96:1421-6.
7. Warren WD, Roberts KL, Linehan LA, Berton MT. Regulation of the germline immunoglobulin Cgammal promoter by CD40 ligand and IL-4: dual role for tandem NF-kappaB binding sites. Mol Immunol 1999;36:31-44.
8. Hornung M, Lindemann D, Kraus C, Peters A, Berberich I. The CD40 TRAF family member interacting motif carries the information to rescue WEHI 231 cells from anti-IGM-induced growth arrest. Eur J Immunol 1998;28:3812-23.
9. Gerritse K, Laman JD, Noelle RJ et al. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 1996;93:2499-504.
10. Boon L, Brok HP, Bauer J et al. Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) Using a Chimeric Antagonist Monoclonal Antibody Against Human CD40 Is Associated with Altered B Cell Responses. J Immunol 2001;167:2942-9.
11. Laman JD, 't Hart BA, Brok HPM et al. Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12) (in press). Eur J Immunol 2002.
12. Menezes J, Leibold W, Klein G, Clements G. Establishment and characterization of an Epstein-Barr virus (EBC) - negative lymphoblastoid B-cell line (BJAB) from an exceptional, EBV- genome-negative African Burkitt's lymphoma. Biomed 1975;22:276-84.
13. Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 1995;182:1265-73.
14. Ellmark P, Ottosson C, Borrebaeck CAK, Malmborg Hager A-C, Furebring C. Modulation of the CD40-CD40 ligand interaction using human anti-CD40 single-chain antibody fragments obtained from the n-CoDeR phage display library. Immunology 2002;106:456-63.
15. Ohlin M, Sundqvist VA, Mach M, Wahren B, Borrebaeck CAK. Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies. J Virol 1993;67:703-10.
16. Malmborg Hager A-C, Michaelsson A, Ohlin M, Jansson B, Borrebaeck CAK. Real time analysis of antibody-antigen reaction kinetics. Scand J Immunol 1992;35:643-50.
17. Gessner JE, Heiken H, Tamm A, Schmidt RE. The IgG Fc receptor family. Ann Hematol 1998;76:231-48.
18. Clynes RA, Towers TL, Presta LG, Ravetch JV. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumour targets. Nat Med 2000;6:443-6.
19. Pound JD, Challa A, Holder MJ et al. Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells. Int Immunol 1999;11:11-20.
20. Kwekkeboom J, De Boer M, Tager JM, De Groot C. CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells. Immunology 1993;79:439-44.
21. Peitsch MC, Jongeneel CV. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumour necrosis factors. Int Immunol 1993;5:233-8.
22. Bajorath J, Chalupny NJ, Marken JS et al. Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction. Biochemistry 1995;34:1833-44.
23. Costello RT, Gastaut JA, Olive D. What is the real role of CD40 in cancer immunotherapy? Immunol Today 1999;20:488-93.
24. Armitage RJ, Fanslow WC, Strockbine L et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992;357:80-2.
25. Bajorath J. Detailed comparison of two molecular models of the human CD40 ligand with an x-ray structure and critical assessment of model-based mutagenesis and residue mapping studies. J Biol Chem 1998;273:24603-9.
26. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001;104:487-501.
27. Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ. A domain in TNF receptors that mediates ligand-independent receptor assembly and signalling. Science 2000;288:2351-4.
28. Siegel RM, Frederiksen JK, Zacharias DA et al. Fas preassociation required for apoptosis signalling and dominant inhibition by pathogenic mutations. Science 2000;288:2354-7.
29. Barr TA, Heath AW. Functional activity of CD40 antibodies correlates to the position of binding relative to CD154. Immunology 2001;102:39-43.
30. Borrebaeck CAK, Carlsson R. Human therapeutic antibodies. Curr Opin Pharmacol 2001;1:404-8.
31. Söderlind E, Strandberg L, Jirholt P et al. Recombining germline-derived CDR sequences for creating diverse single- framework antibody libraries. Nat Biotechnol 2000;18:852-6.